Trial Details
UNKNOWNBasic Information
| Clinical ID | c2377 |
|---|---|
| Identifier | NCT03580876 |
| Trial Title | Addition of Azathioprine in IBD Patients With Immunogenic Failure |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Clinical Failure After Switch |
| Interventions | DRUG: addition of azathioprine|DRUG: Switch to a second anti-TNF drug alone |
Participant Information
| Sponsor | Védrines, Philippe, M.D. |
|---|---|
| City | Pays de la Loire Region |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2018-07-23 |
|---|---|
| Primary Completion Date | 2019-06-10 |
| Completion Date | 2020-06-10 |